InsidersTradesSigma
Track the 诚达药业 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 诚达药业 has logged 1 public disclosures. Market capitalisation: €4.2bn. The latest transaction was filed on 21 January 2022 (Sale). Among the most active insiders: 陈小红. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Chengda Pharmaceutical 是一家在 XSHE 市场上市的医疗保健和制药公司。它专注于创新药物的开发和生产。